Finance

Lists
1276:HKG
Jiangsu Hengrui Pharmaceuticals Co Ltd
HK$ 47.60
-0.83%
(-0.40) 1D
10-р сарын 16, 16:08:14 (GMT+8)  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1276...
Open
HK$ 48.00
High
HK$ 49.30
Low
HK$ 46.92
Mkt. cap
347.27Т
Avg. vol.
4.04 сая
Volume
4.16 сая
P/E ratio
34.86
52-wk high
HK$ 84.50
52-wk low
HK$ 43.02
EPS
HK$ 1.37
No. of employees
21 мян
Open
HK$ 48.00
High
HK$ 49.30
Low
HK$ 46.92
Mkt. cap
347.27Т
Avg. vol.
4.04 сая
Volume
4.16 сая
P/E ratio
34.86
52-wk high
HK$ 84.50
52-wk low
HK$ 43.02
EPS
HK$ 1.37
No. of employees
21 мян
News stories
From web sources and news partners
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees20.7 мян
Founded1970
Headquarters-
SectorPharmaceutical industry
Next call 10 өдрийн дараа
10-р сарын 27. Мя, 09:00
Fiscal period
Q3 2026
- / CN¥ 0.31
Revenue / Est. (CNY)
- / 9.17 тэрбум
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
7.43 тэрбум
8.44 тэрбум
8.14 тэрбум
7.32 тэрбум
Cost of goods sold
1.07 тэрбум
1.25 тэрбум
1.09 тэрбум
1.02 тэрбум
Cost of revenue
1.07 тэрбум
1.25 тэрбум
1.09 тэрбум
1.02 тэрбум
Research and development expenses
1.72 тэрбум
2.02 тэрбум
1.65 тэрбум
1.84 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.23 тэрбум
3.01 тэрбум
2.81 тэрбум
2.78 тэрбум
Operating expense
4.76 тэрбум
5.35 тэрбум
4.48 тэрбум
4.61 тэрбум
Total operating expenses
5.83 тэрбум
6.60 тэрбум
5.57 тэрбум
5.63 тэрбум
Operating income
1.60 тэрбум
1.84 тэрбум
2.57 тэрбум
1.68 тэрбум
Other non operating income
-154.21 сая
145.74 сая
-345.12 сая
243.91 сая
EBT including unusual items
1.36 тэрбум
2.30 тэрбум
2.56 тэрбум
2.40 тэрбум
EBT excluding unusual items
1.68 тэрбум
1.91 тэрбум
2.55 тэрбум
1.60 тэрбум
Income tax expense
55.51 сая
338.85 сая
275.87 сая
211.27 сая
Effective tax rate
4.08%
14.76%
10.79%
8.82%
Other operating expenses
-217.30 сая
326.84 сая
4.76 сая
-5.09 сая
Net income
1.30 тэрбум
1.96 тэрбум
2.28 тэрбум
2.18 тэрбум
Net profit margin
17.52%
23.22%
28.04%
29.84%
Earnings per share
0.20
-
-
-
Interest and investment income
242.14 сая
288.66 сая
322.96 сая
448.28 мян
Interest expense
-689.68 мян
-2.00 сая
-448.28 мян
-322.96 сая
Net interest expenses
241.45 сая
286.66 сая
322.52 сая
-322.52 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.78 тэрбум
2.04 тэрбум
2.77 тэрбум
1.93 тэрбум
Gain or loss from assets sale
2.31 сая
-4.05 сая
-
-40.62 сая
AI content may include mistakes. Learn more
Google аппс